Does SIROLIMUS Cause Malignant neoplasm progression? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Malignant neoplasm progression have been filed in association with SIROLIMUS (sirolimus). This represents 0.5% of all adverse event reports for SIROLIMUS.
53
Reports of Malignant neoplasm progression with SIROLIMUS
0.5%
of all SIROLIMUS reports
25
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SIROLIMUS?
Of the 53 reports, 25 (47.2%) resulted in death, 6 (11.3%) required hospitalization, and 2 (3.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIROLIMUS. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does SIROLIMUS Cause?
Off label use (1,960)
Drug ineffective (1,005)
Product use in unapproved indication (984)
Transplant rejection (698)
Pneumonia (599)
Product use issue (506)
Alopecia (491)
Acne (482)
Transplant dysfunction (468)
Condition aggravated (433)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SIROLIMUS Alternatives Have Lower Malignant neoplasm progression Risk?
SIROLIMUS vs SIRUKUMAB
SIROLIMUS vs SITAGLIPTIN
SIROLIMUS vs SOAP
SIROLIMUS vs SODIUM
SIROLIMUS vs SODIUM BICARBONATE